As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...